These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26302115)

  • 1. [Leprosy in Yucatan, retrospective clinical study of 63 years (1950-2013)].
    Atoche C; Torres-Guerrero E; Vargas F; Arenas R
    Salud Publica Mex; 2015; 57(3):191-2. PubMed ID: 26302115
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse rates following leprosy multidrug therapy.
    Suite M
    West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of leprosy. Report of a WHO Study Group.
    World Health Organ Tech Rep Ser; 1994; 847():1-24. PubMed ID: 7817604
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 7. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the treatment of leprosy.
    Ishii N
    Dermatol Online J; 2003 Mar; 9(2):5. PubMed ID: 12639458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding Brasil, et al.'s adverse effects in leprosy's WHO/MDT and paramedic's role in leprosy control program.
    Cunha Mda G; Schettini AP; Pereira ES; Pedrosa VL; Cruz RC; Sadahiro M
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):257-9. PubMed ID: 9251600
    [No Abstract]   [Full Text] [Related]  

  • 11. A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
    Thangaraju P; Venkatesan S
    Lancet; 2019 Oct; 394(10207):1450. PubMed ID: 31631856
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in leprosy clinical pattern after multidrug therapy implementation.
    Martelli CM; Andrade AL; Grossi MA; Leboeuf MA; Lombardi C; Zicker F
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):95-7. PubMed ID: 7730726
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in new case-detection rates at the Leprosy Mission Trust India centres.
    Sundar Rao PS; Jayakumar S
    Indian J Lepr; 2006; 78(2):187-94. PubMed ID: 16927852
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
    World Health Organization
    Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
    [No Abstract]   [Full Text] [Related]  

  • 15. Leprosy disabilities: magnitude of the problem.
    Wkly Epidemiol Rec; 1995 Sep; 70(38):269-75. PubMed ID: 7577430
    [No Abstract]   [Full Text] [Related]  

  • 16. How can adherence with multi-drug therapy in leprosy be improved?
    Williams MC
    Lepr Rev; 2005 Jun; 76(2):160-1. PubMed ID: 16038249
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur).
    Singh H; Nel B; Dey V; Tiwari P; Dulhani N
    Lepr Rev; 2011 Mar; 82(1):17-24. PubMed ID: 21644468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug therapy in the control of leprosy. A field study.
    Becx-Bleumink M
    Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leprosy in The Netherlands in the period 1970-1991].
    Post E; chin-A-Lien RA; Bouman C; Naafs B; Faber WR
    Ned Tijdschr Geneeskd; 1994 Sep; 138(39):1960-3. PubMed ID: 7935946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.